Does Placebo Information Affect the Trial Outcomes and Participant Blinding?

NACompletedINTERVENTIONAL
Enrollment

89

Participants

Timeline

Start Date

October 7, 2019

Primary Completion Date

December 20, 2019

Study Completion Date

December 20, 2019

Conditions
Muscle Soreness
Interventions
DEVICE

acupuncture

A sterilised stainless steel needle (diameter 0.25mm X length 40mm, Dongbang Acupuncture Inc., Boryeong, Chungchenongnam-do, Korea) will be given at PC3, LI4, LI11, and LU5 of non-dominant arm for 15 minutes once a day for 3 days (immediately after inducing delayed onset muscle soreness (DOMS), and 2 consecutive days after inducing DOMS).

DEVICE

Park Sham Needle

A Park Sham Needle (Meridius Medical Ltd. \& DongBang Acuprime Ltd., Exeter, UK), non-penetrating sham acupuncture, will be given at two points on the belly of biceps brachii, 1 cun proximedially from LI11, and 1 cun laterally from PC3 of non-dominant arm for 15 minutes once a day for 3 days (immediately after inducing delayed onset muscle soreness (DOMS), and 2 consecutive days after inducing DOMS).

Trial Locations (1)

02447

Acupuncture & Meridian Science Research Centre, Seoul

All Listed Sponsors
collaborator

University of California, Davis

OTHER

lead

Kyunghee University

OTHER

NCT04182295 - Does Placebo Information Affect the Trial Outcomes and Participant Blinding? | Biotech Hunter | Biotech Hunter